Learn About Aortic Valve Replacement
General Surgery
NewYork-Presbyterian Healthcare System
Cleveland Clinic Main Campus
Stephanie Mick is a Thoracic Surgeon and a General Surgeon in Cleveland, Ohio. Mick has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in Aortic Valve Replacement. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Valve Prolapse, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). She is licensed to treat patients in Ohio and New York.
Cardiology
NewYork-Presbyterian Healthcare System
NewYork-Presbyterian/Columbia University Irving Medical Center
Ajay Kirtane is an Interventional Cardiologist and a Cardiologist in New York, New York. Kirtane has been practicing medicine for over 25 years and is rated as an Elite expert by MediFind in Aortic Valve Replacement. He is also highly rated in 33 other conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in Massachusetts, California, and New York. Kirtane is currently accepting new patients.
General Surgery
NewYork-Presbyterian Healthcare System
CUMC/Milstein Hospital Building
Isaac George is a Thoracic Surgeon and a General Surgeon in New York, New York. George has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in Aortic Valve Replacement. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Aortic Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in New York. George is currently accepting new patients.
Summary: The primary purpose of the LAA-CLOSURE trial is to assess the efficacy and safety of surgical closure of LAA in patients undergoing aortic valve replacement. This randomized, prospective, open-label international multicenter trial will enroll 1040 patients undergoing aortic valve replacement with CHA2DS2-VASC score ≥2 but without an indication for anticoagulation at the time of enrollment. Patient...
Summary: TAVR is an increasingly used technique for the treatment of aortic valve stenosis. However, recent clinical experience has suggested that subclinical aortic valve bioprosthesis thrombosis may occur early after valve replacement. The frequency of this potentially ominous phenomenon on both transcatheter and surgical aortic valve bioprosthesis is unknown, as this condition is difficult to detect. Th...